{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:59:41Z","timestamp":1761922781275,"version":"build-2065373602"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":663,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p> <jats:bold>\n            <jats:italic>\n              Objective:\n            <\/jats:italic>\n          <\/jats:bold> Originally introduced into pharmacotherapy as an antiviral compound, amantadine was shown to also have multiple pharmacological effects on the central nervous system. In addition, only a few studies reported on certain antidepressive properties of amantadine. This effect was highlighted by the discovery of its antiviral effect on Borna disease virus (BDV), which is hypothesized to be an etiopathogenetic factor to subtypes of affective disorders. Therefore, the therapeutical use of amantadine in BDV\u2010infected depressive patients was investigated. \u2028\u2028<jats:bold><jats:italic>Methods:<\/jats:italic><\/jats:bold> In this open trial, amantadine was added to antidepressive and\/or mood\u2010stabilizing compounds treating BDV\u2010infected depressed patients (n=25) with bipolar or major depressive disorders. Amantadine was given twice a day (100\u2013300 mg\/day) for a mean of 11 weeks. Antidepressive treatment response was measured on the Hamilton rating scale for depression (HAM\u2010D) and\/or with an operationalized diagnostic criteria system (OPCRIT; version 3.31). Virological response was measured by expression of BDV infection parameters in blood samples. \u2028\u2028<jats:bold><jats:italic>Results:<\/jats:italic><\/jats:bold> The overall response rate of the amantadine augmentation in the BDV\u2010infected patients with regard to depressive symptoms was 68% after a mean of 2.9 weeks of treatment. Bipolar I patients improved faster and did not show any following hypomania. In addition, the decrease of depression tended to correspond with the decrease in viral activity. \u2028\u2028<jats:bold><jats:italic>Conclusion:<\/jats:italic><\/jats:bold> Amantadine appears to show a remarkable antidepressive efficacy in BDV\u2010infected depressive patients. The antidepressive effect in this open trial appeared to be comparable to standard antidepressives, possibly being a result of its antiviral effect against BDV as a potentially relevant etiopathogenetic factor in these disorders.<\/jats:p>","DOI":"10.1034\/j.1399-5618.2000.020110.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T04:48:12Z","timestamp":1047358092000},"page":"65-70","source":"Crossref","is-referenced-by-count":42,"title":["Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial"],"prefix":"10.1111","volume":"2","author":[{"given":"Detlef E","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liv","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten W","family":"Spannhuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonita","family":"Brodhun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinderk M","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"107","article-title":"Borna disease: a persistent virus infection of the central nervous system","volume":"35","author":"Ludwig H","year":"1988","journal-title":"Prog Med Virol"},{"key":"e_1_2_7_3_2","first-page":"2321","article-title":"The order Mononegavirales\u2003\u2013\u2003current status","volume":"142","author":"Pringle CR","year":"1997","journal-title":"Arch Virol"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01315014"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.61.11.3431-3440.1987"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00189527"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","unstructured":"Gosztonyi G Ludwig H. Borna disease\u2010neuropathology and pathogenesis. In: Koprowski H Lipkin WI eds. Borna Disease. Current Topics in Microbiological Immunology. Berlin: Springer 1995; 190: 39\u201373.","DOI":"10.1007\/978-3-642-78618-1_4"},{"key":"e_1_2_7_8_2","first-page":"167","article-title":"Clinical similarities and close genetic relationship of human and animal Borna disease virus","volume":"13","author":"Bode L","year":"1997","journal-title":"Arch Virol"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02121228"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6602380"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(89)90122-4"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","unstructured":"Stitz L Dietzschold B Carbone KM. Immunopathogenesis of Borna disease. In: Koprowski H Lipkin WI eds. Borna Disease. Current Topics in Microbiological Immunololgy. Berlin: Springer 1995; 190: 75\u201392.","DOI":"10.1007\/978-3-642-78618-1_5"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000150545"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3922055"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890360414"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0395-232"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00406-Y"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.70.11.7713-7724.1996"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1996.tb01094.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09941.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-9300-6_13"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979305"},{"key":"e_1_2_7_23_2","first-page":"200","article-title":"First isolates of infectious human Borna disease virus from patients with mood disorders","volume":"1","author":"Bode L","year":"1996","journal-title":"Mol Psychiatry"},{"key":"e_1_2_7_24_2","first-page":"107","article-title":"Neurotransmitter receptors and viral neurotropism","volume":"3","author":"Gosztonyi G","year":"1984","journal-title":"Neuropsychiat Clin"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90627-0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00480-7"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0479"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","unstructured":"Salvatore M Morzunov S Schwemmle M Lipkin WI and the Bornavirus Study Group. Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorders. Lancet 1997; 349: 1813\u20131814.","DOI":"10.1016\/S0140-6736(05)61693-5"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79891-3"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.144.3620.862"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)90153-X"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60979-8"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979191"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050220"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050221"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004300050064"},{"key":"e_1_2_7_37_2","unstructured":"American Psychiatric Association. Diagnostic criteria from DSM\u2010IV. Washington DC: American Psychiatric Association (APA) 1994"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"e_1_2_7_39_2","unstructured":"McGuffin P Farmer AE Williams J. Operational Criteria (OPCRIT) Checklist Version 3.31 UWCM Cardiff Wales 1993."}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-5618.2000.020110.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-5618.2000.020110.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-5618.2000.020110.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:32:53Z","timestamp":1698579173000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-5618.2000.020110.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1034\/j.1399-5618.2000.020110.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-5618.2000.020110.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"type":"print","value":"1398-5647"},{"type":"electronic","value":"1399-5618"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}